Impact of Antidepressant Use on the Trajectory of Alzheimer’s Disease: Evidence, Mechanisms, and Therapeutic Implications

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression

(2018) Claudia Bartels et al.   AMERICAN JOURNAL OF PSYCHIATRY

Late-Life Depression as a Risk Factor for Mild Cognitive Impairment or Alzheimer's Disease in 30 US Alzheimer's Disease Centers

(2018) Kyle Steenland et al.   JOURNAL OF ALZHEIMERS DISEASE

Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E

(2017) Shanna L. Burke et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria

(2017) Zahinoor Ismail et al.   INTERNATIONAL PSYCHOGERIATRICS

The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations

(2017) Zahinoor Ismail et al.   JOURNAL OF ALZHEIMERS DISEASE

Dementia prevention, intervention, and care

(2017) Gill Livingston et al.   LANCET

Prevalence of Depression in Patients With Mild Cognitive Impairment

(2017) Zahinoor Ismail et al.   JAMA Psychiatry

Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan

(2017) Chee-Kin Then et al.   PLoS One

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis

(2016) John Moraros et al.   DEPRESSION AND ANXIETY

Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo

(2016) Jonathan R. Fisher et al.   Molecular Neurodegeneration

The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI

(2016) Gábor Csukly et al.   Frontiers in Aging Neuroscience

The Prevalence of Depression in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

(2015) Song Chi et al.   Current Alzheimer Research

Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease

(2015) Young Min Choe et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

(2015) Frances K. Wiseman et al.   NATURE REVIEWS NEUROSCIENCE

Progression of mild cognitive impairment to dementia due to AD in clinical settings

(2015) Karim Tifratene et al.   NEUROLOGY

Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data

(2015) Connie Sanchez et al.   PHARMACOLOGY & THERAPEUTICS

Effect of Citalopram on Agitation in Alzheimer Disease

(2014) Anton P. Porsteinsson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Antidepressants on Longevity and Dementia Onset Among Adults With Down Syndrome

(2014) John A. Tsiouris et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia

(2014) Sarah K. Dutcher et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Comparison of Sertraline, Venlafaxine and Desipramine Effects on Depression, Cognition and the Daily Living Activities in Alzheimer Patients

(2014) N. Mokhber et al.   PHARMACOPSYCHIATRY

An Antidepressant Decreases CSF A  Production in Healthy Individuals and in Transgenic AD Mice

(2014) Y. I. Sheline et al.   Science Translational Medicine

Cognitive Outcomes After Sertaline Treatment in Patients With Depression of Alzheimer Disease

(2012) Cynthia A. Munro et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

(2012) P. B. Rosenberg et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study

(2012) Joseph S. Goveas et al.   INTERNATIONAL PSYCHOGERIATRICS

Temporal Relationship Between Depression and Dementia

(2011) Ge Li   ARCHIVES OF GENERAL PSYCHIATRY

Risk Profiles of Subtypes of Mild Cognitive Impairment: The Sydney Memory and Ageing Study

(2011) Perminder S. Sachdev et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

(2011) Sube Banerjee et al.   LANCET

Serotonin signaling is associated with lower amyloid-  levels and plaques in transgenic mice and humans

(2011) J. R. Cirrito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies

(2009) A. J. Mitchell et al.   ACTA PSYCHIATRICA SCANDINAVICA

Risk Factors of Transition from Normal Cognition to Mild Cognitive Disorder: The PATH through Life Study

(2009) Nicolas Cherbuin et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets

(2009) Filippo Caraci et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

(2009) Luca Rozzini et al.   INTERNATIONAL PSYCHOGERIATRICS

Antidepressants and dementia

(2009) Lars Vedel Kessing et al.   JOURNAL OF AFFECTIVE DISORDERS

Is Antidepressant Treatment Associated with Reduced Cognitive Decline in Alzheimer’s Disease?

(2008) Enrico Mossello et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS